Merck To Market Biken Flu Vaccines In Japan
This article was originally published in PharmAsia News
Executive Summary
Merck &Co. Japanese subsidiary Merck, Sharp & Dohme Japan has signed an agreement with Osaka University Research Institute for Microbial Disease (Biken) to market Biken seasonal flu vaccines.